Top

Published in:

01-12-2014 | Review

Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms

Authors: Bingjiang Xia, Di Chen, Jushi Zhang, Songfeng Hu, Hongting Jin, Peijian Tong

Published in: Calcified Tissue International | Issue 6/2014

Abstract

Osteoarthritis (OA), the most prevalent chronic joint disease, increases in prevalence with age, and affects majority of individuals over the age of 65 and is a leading musculoskeletal cause of impaired mobility in the elderly. Because the precise molecular mechanisms which are involved in the degradation of cartilage matrix and development of OA are poorly understood and there are currently no effective interventions to decelerate the progression of OA or retard the irreversible degradation of cartilage except for total joint replacement surgery. In this paper, the important molecular mechanisms related to OA pathogenesis will be summarized and new insights into potential molecular targets for the prevention and treatment of OA will be provided.

Dahaghin S, Bierma-Zeinstra SM, Ginai AZ et al (2005) Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability. Ann Rheum Dis 64:682–687PubMedCentralPubMed

Oliveria SA, Felson DT, Reed JI et al (1995) Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 38:1134–1141PubMed

Dillon CF, Rasch EK, Gu Q et al (2006) Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Surgery 1991–94. J Rheumatol 33:2271–2279PubMed

Felson DT (1988) Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 10:1–28PubMed

March LM, Bachmeier CJ (1997) Economics of osteoarthritis: a global perspective. Baillieres Clin Rheumatol 11:817–834PubMed

Rai MF, Sandell LJ (2011) Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr 21:131–142PubMed

Mobasheri A (2012) Osteoarthritis year 2012 in review: biomarkers. Osteoarthr Cartil 20(12):1451–1464PubMed

Felson DT (2006) Osteoarthritis of the knee. NEJM 354:841–848PubMed

Goldring MB, Goldring SR (2007) Osteoarthritis. J Cel Physiol 213:626–634

10.

Ettinger WH Jr, Burns R, Messier SP et al (1997) A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: the fitness arthritis and seniors trial (FAST). JAMA 277:25–31PubMed

11.

Messier SP, Loeser RF, Miller GD et al (2004) Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum 50:1501–1510PubMed

12.

Berman BM, Lao L, Langenberg P et al (2004) Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 141:901–910PubMed

13.

Bottegoni C, Muzzarelli RA, Giovannini F et al (2014) Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis. Carbohydr Polym 109:126–138PubMed

14.

Leopold SS (2009) Minimally invasive total knee arthroplasty for osteoarthritis. N Engl J Med 360:1749–1758PubMed

15.

Krasonkutsky S, Samuels J, Abramson SB (2007) Osteoarthritis in 2007. Bull NYU Hosp Jt Dis 65:222–228

16.

Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 427:S6–S15PubMed

17.

Jackson A, Gu W (2009) Transport properties of cartilaginous tissues. Curr Rheumatol Rev 5:40PubMedCentralPubMed

18.

Eyre DR, Wu JJ, Fermandes RJ et al (2002) Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans 30:893–899PubMed

19.

Knudson CB, Knudson W (2001) Cartilage proteoglycans. Semin Cell Dev Biol 12:69–78PubMed

20.

Woods A, Wang G, Beier F (2007) Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol 213:1–8PubMed

21.

Goldring MB, Marcu KB (2009) Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 11:224PubMedCentralPubMed

22.

Kannu P, Bateman JF, Belluoccio D (2009) Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis. Arthritis Rheum 60:325–334PubMed

23.

Iozzo RV (2000) Proteoglycans: structure, biology and molecular interactions, 1st edn. Thomas Jefferson University, Jefferson Medical College, Philadelphia

24.

Verzijl N, DeGroot J, Thorpe SR (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 275:39027–39031PubMed

25.

Pacifici M, Koyama E, Iwamoto M (2005) Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Res 75:237–248

26.

Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann NY Acad Sci 1192:230–237PubMed

27.

Mort JS, Billington CJ (2001) Articular cartilage and changes in arthritis matrix degradation. Arthritis Res 3:337–341PubMedCentralPubMed

28.

Ding CH, Martel-Pelletier J, Pelletier JP et al (2007) Meniscal tear as an osteoarthritis risk factor in a largely non-osteoarthritic cohort: a cross-sectional study. J Rheumatol 34:776–784PubMed

29.

Hunter DJ, Zhang YQ, Niu JB et al (2006) The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum 54:795–801PubMed

30.

Clements KM, Price JS, Chambers MG et al (2003) Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transaction of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 48:3452–3463PubMed

31.

Li Y, Xu L, Olsen BR (2007) Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease. Osteoarthr Cartil 15:1101–1105PubMedCentralPubMed

32.

Kannu P, Bateman JF, Belluoccio D et al (2009) Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis. Arthritis Rheum 60:325–334PubMed

33.

Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm 2014:561459

34.

van der Kraan PM, Goumans MJ, Blaney Davidson E et al (2012) Age-dependent alteration of TGF-β signalling in osteoarthritis. Cell Tissue Res 347:257–265PubMedCentralPubMed

35.

Kolpakova E, Olsen BR (2005) Wnt/beta-catenin-a canonical tale of cell-fate choice in the vertebrate skeleton. Dev Cell 8:626–627PubMed

36.

Komori T (2003) Requisite roles of Runx2 and Cbfb in skeletal development. J Bone Miner Metab 21:193–197PubMed

37.

Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332–336PubMed

38.

Degnin CR, Laederich MB, Horton WA (2010) FGFs in endochondral skeletal development. J Cell Biochem 110:1046–1057PubMed

39.

Schmidt MB, Chen EH, Lynch SE (2006) A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil 14:403–412PubMed

40.

Blaney Davidson EN, Vitters EL, van der Kraan PM et al (2006) Expression of transforming growth factor-β (TGF-β) and the TGF-β signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis 65:1414–1421PubMed

41.

Miyazawa K, Shinozaka M, Hara T et al (2002) Two major Smad pathways in TFG-β superfamily signaling. Genes Cells 7:1191–1204PubMed

42.

Nicole D, Kerstin K (2000) Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development and adult homeostasis. Eur J Bioche 267:6982–6988

43.

Serra R, Johnson M, Filvaroff EH et al (1997) Expression of a truncated, kinase-defective TGF-b type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541–552PubMedCentralPubMed

44.

Yang X, Chen L, Xu X et al (2001) TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153:35–46PubMedCentralPubMed

45.

Chen M, Lichtler AC, Sheu T et al (2007) Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 45:44–50PubMedCentralPubMed

46.

Zhu M, Chen M, Lichlter AC et al (2008) Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreERT2 transgenic mice. Osteoarthr Cartil 16:129–130PubMedCentralPubMed

47.

Shen J, Li J, Wang B et al (2013) Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum 65:3107–3119PubMedCentralPubMed

48.

Valdes AM, Spector TD, Tamm A et al (2010) Genetic variation in the smad3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 62:2347–2352PubMed

49.

Zhen G, Wen C, Jia X et al (2013) Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704–712PubMedCentralPubMed

50.

Blaney Davidson EN, van der Kraan PM, van den Berg WB (2007) TGF-beta and osteoarthritis. Osteoarthritis Cartilage 15:597–604PubMed

51.

Fortier LA, Barker JU, Strauss EJ et al (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469:2706–2715PubMedCentralPubMed

52.

Chia SL, Sawaji Y, Burleigh A et al (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 60:2019–2027PubMed

53.

Cucchiarini M, Terwilliger EF, Kohn D et al (2009) Remodelling of human osteoarthritic cartilage by FGF-2, alone or combined with Sox9 via rAAV gene transfer. J Cell Mol Med 13:2476–2488PubMed

54.

Li X, Ellman MB, Kroin JS et al (2012) Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. J Cell Biochem 113:2532–2542PubMedCentralPubMed

55.

Im HJ, Muddasani P, Natarajan V et al (2007) Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase c pathways in human adult articular chondrocytes. J Biol Chem 282:11110–11121PubMedCentralPubMed

56.

Ellman MB, An HS, Muddasani P et al (2008) Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420:82–89PubMedCentralPubMed

57.

Ellman M, Kim J, An H et al (2011) The pathophysiological role of the PKCδ pathway in the intervertebral disc: in vitro, ex vivo and in vivo studies. Arthritis Rheum 64:1950–1959PubMedCentralPubMed

58.

Yan D, Chen D, Im HJ (2012) Fibroblast growth factor-2 promotes catabolism via FGFR1–Ras–Raf–MEK1/2–ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes. J Cell Biochem 113:2856–2865PubMedCentralPubMed

59.

Andrew SL, Michael BE, Dongyao Y et al (2013) A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 527:440–447

60.

Maruoka Y, Ohbayashi N, Hoshikawa M et al (1998) Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo. Mech Dev 74:175–177PubMed

61.

Usui H, Shibayama M, Ohbayashi N et al (2004) FGF18 is required for embryonic lung alveolar development. Biochem Biophys Res Comm 322:887–892PubMed

62.

Davidson D, Blanc A, Filion D (2005) Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280:20509–20515PubMed

63.

Liu Z, Lavine KJ, Hung IH et al (2007) FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol 302:80–91PubMed

64.

Carli A, Gao C, Khayyat-Kholghi M et al (2012) FGF 18 augments osseointegration of intra-medullary implants in osteopenic FGFR3(−/−) mice. Eur Cell Mater 24:116–117

65.

Moore EE, Bendele AM, Thompson DL et al (2005) Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 13:623–631PubMed

66.

Power J, Hernandez P, Guehring H et al (2014) Intraarticular injection of rhFGF-18 improves the healing in microfracture treated chondral defects in an ovine model. J Orthop Res 32:669–676PubMed

67.

Barr L, Getgood A, Guehring H et al (2014) The effect of recombinant human fibroblast growth factor-18 on articular cartilage following single impact load. J Orthop Res 32:923–927PubMed

68.

Geetha-Loganathan P, Nimmagadda S, Scaal M (2008) Wnt signaling in limb organogenesis. Organogenesis 4:109–115

69.

Loughlin J, Mustafa Z, Smith A et al (2000) Linkage analysis of chromosome 2q in osteoarthritis. Rheumatology 39:377–381PubMed

70.

Loughlin J, Dowling B, Chapman K et al (2004) Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci USA 101:9757–9762PubMedCentralPubMed

71.

Valdes AM, Doherty S, Muir KR et al (2012) Genetic contribution to radiographic severity in osteoarthritis of the knee. Ann Rheum Dis 71:1537–1540PubMedCentralPubMed

72.

Min JL, Meulenbelt I, Riyazi N et al (2005) Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum 52:1077–1080PubMed

73.

Lories RJ, Peeters J, Bakker A et al (2007) Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum 56:4095–4103PubMed

74.

Lodewyckx L, Cailotto F, Thysen S et al (2012) Tight regulation of wingless-type signaling in the articular cartilage subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther 14:R16PubMedCentralPubMed

75.

Zhu M, Tang D, Wu Q et al (2009) Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J Bone Miner Res 24:12–21PubMedCentralPubMed

76.

Wu Q, Huang JH, Sampson ER et al (2009) Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp Cell Res 315:2386–2398PubMedCentralPubMed

77.

Blom AB, Brockbank SM, van Lent PL et al (2009) Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 60:501–512PubMed

78.

Zhu M, Chen M, Zuscik M et al (2008) Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum 58:2053–2064PubMedCentralPubMed

79.

Alcaraz MJ, Megías J, García-Arnandis I et al (2010) New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol 80:13–21PubMed

80.

Huang SM, Mishina YM, Liu S et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620PubMed

81.

Lane NE, Nevitt MC, Lui LY et al (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56:3319–3325PubMed

82.

Diarra D, Stolina M, Polzer K et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156–163PubMed

83.

Tamamura Y, Otani T, Kanatani N et al (2005) Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280:19185–19195PubMed

84.

Lin AC, Seeto BL, Bartoszko JM et al (2009) Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15:1421–1426PubMed

85.

Mak KK, Kronenberg HM, Chuang P-T et al (2008) Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 135:1947–1956PubMed

86.

Beaupre GS, Stevens SS, Carter DR (2000) Mechanobiology in the development, maintenance, and degeneration of articular cartilage. J Rehabil Res Dev 37:145–151PubMed

87.

Lin AC, Seeto BL, Bartoszko JM et al (2009) Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15:1421–1425PubMed

88.

Ushijima Takahiro, Okazaki Ken, Tsushima Hidetoshi et al (2014) CCAAT/enhancer binding protein β regulates expression of Indian Hedgehog during chondrocytes differentiation. PLoS ONE 9:e104547PubMedCentralPubMed

89.

Zhou J, Wei X, Wei L (2014) Indian Hedgehog, a critical modulator in osteoarthritis, could be a potential therapeutic target for attenuating cartilage degeneration disease. Connect Tissue Res 55:257–261PubMed

90.

Semenza GL (2011) Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 76:347–353PubMed

91.

Lando D, Peet DJ, Whelan DA et al (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858–861PubMed

92.

Bracken CP, Whitelaw ML, Peet DJ (2003) The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 60:1376–1393PubMed

93.

Kiss J, Kirchberg J, Schneider M (2012) Molecular oxygen sensing: implications for visceral surgery. Langenbecks Arch Surg 397(4):603–610PubMed

94.

Duval E, Leclercq S, Elissalde JM et al (2009) Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1 alpha-dependent redifferentiation of chondrocytes. Arthritis Rheum 60:3038–3048PubMed

95.

Pfander D, Cramer T, Schipani E et al (2003) HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116:1819–1826PubMed

96.

Saito T, Fukai A, Mabuchi A et al (2010) Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16:678–686PubMed

97.

Yang S, Kim J, Ryu JH et al (2010) Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16:687–693PubMed

98.

Muraki S, Oka H, Akune T et al (2009) Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil 17:1137–1143PubMed

99.

Lafont JE, Talma S, Murphy CL (2007) Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum 56:3297–3306PubMed

100.

Lafont JE, Talma S, Hopfgarten C et al (2008) Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways. J Biol Chem 283:4778–4786PubMed

101.

Domm C, Schunke M, Christesen K et al (2002) Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthr Cartil 10:13–22PubMed

102.

Khan WS, Adesida AB, Hardingham TE (2007) Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 9:R55PubMedCentralPubMed

103.

van den Berg WB (2011) Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthr Cartil 19:338–341PubMed

104.

Wang M, Shen J, Jin H et al (2011) Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann NY Acad Sci 1240:61–69PubMedCentralPubMed

105.

Buxton P, Edwards C, Archer CW et al (2001) Growth/differentiation factor-5 (GDF-5) and skeletal development. J Bone Joint Surg Am 83:23–30

106.

Francis-West PH, Abdelfattah A, Chen P et al (1999) Mechanisms of GDF-5 action during skeletal development. Development 126:1305–1315PubMed

107.

Nishitoh H, Ichijo H, Kimura M (1996) Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345–21352PubMed

108.

Mikic B, Battaglia TC, Taylor EA (2002) The effect of growth/differentiation factor-5 deficiency on femoral composition and mechanical behavior in mice. Bone 30:733–737PubMed

109.

Masuya H, Nishida K, Furuichi T et al (2007) A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. Hum Mol Genet 16:2366–2375PubMed

110.

Chhabra A, Tsou D, Clark RT et al (2003) GDF-5 deficiency in mice delays Achilles tendon healing. J Orthop Res 21:826–835PubMed

111.

Harada M, Takahara M, Zhe P et al (2007) Developmental failure of the intra-articular ligaments in mice with absence of growth differentiation factor 5. Osteoarthr Cartil 15:468–474PubMed

112.

Nickel J, Kotzsch A, Sebald W (2005) A single residue of GDF-5 defines binding specificity to BMP receptor IB. J Mol Biol 349:933–947PubMed

113.

Byrnes AM, Racacho L, Nikkel SM et al (2010) Mutations in GDF5 presenting as semidominant brachydactyly A1. Hum Mutat 31:1155–1162PubMed

114.

Miyamoto Y, Mabuchi A, Shi D et al (2007) A functional polymorphism in the 5′-UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39:529–533PubMed

115.

Byrnes AM, Racacho L, Nikkel SM et al (2010) Mutations in GDF5 presenting as semidominant brachydactyly A1. Hum Mutat 31:1155–1162PubMed

116.

Egli R, Southam L, Wilkins JM et al (2009) Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum 60:2055–2064PubMed

117.

Tsezou A, Satra M, Oikonomou P et al (2008) The growth differentiation factor 5 (GDF5) core promoter polymorphism is not associated with knee osteoarthritis in the Greek population. J Orthop Res 26:136–140PubMed

118.

Storm EE, Huynh TV, Copeland NG et al (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGFb-superfamily. Nature 368:639–643PubMed

119.

Takahara M, Harada M, Guan D et al (2004) Developmental failure of phalanges in the absence of growth/differentiation factor 5. Bone 35:1069–1076PubMed

120.

Daans M, Luyten FP, Lories RJ (2011) GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis 70:208–213PubMed

121.

Mikic B, Clark RT, Battaglia TC (2004) Altered hypertrophic chondrocyte kinetics in GDF-5 deficient murine tibial growth plates. J Orthop Res 22:552–556PubMed

122.

Bobacz K, Gruber R, Soleiman A et al (2002) Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthr Cartil 10:394–401PubMed

123.

Chubinskaya S, Segalite D, Pikovsky D et al (2008) Effects induced by BMPs in cultures of human articular chondrocytes: comparative studies. Growth Factors 26:275–283PubMed

124.

Ratnayake M, Plöger F, Santibanez-Koref M et al (2014) Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5. PLoS ONE 9:e86590PubMedCentralPubMed

125.

Borden P, Heller RA (1997) Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 7:159–178PubMed

126.

Mengshol JA, Vincenti MP, Coon CI (2000) Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43:801–811PubMed

127.

Vincenti MP, Coon CI, Mengshol JA et al (1998) Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem J 331:341–346PubMedCentralPubMed

128.

Vincenti MP (2001) The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 151:121–148PubMed

129.

Shiomi T, Lemaître V, D’Armiento J et al (2010) Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int 60:477–496PubMedCentralPubMed

130.

Knäuper V, Lopez Otin C, Smith B, Knight G (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271:1544–1550PubMed

131.

Walling HW, Raggatt LJ, Irvine DW et al (2003) Impairment of the collagenase-3 endocytotic receptor system in cells from patients with osteoarthritis. Osteoarthr Cartil 11:854–863PubMed

132.

Roach HI, Yamada N, Cheung KS et al (2005) Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52:3110–3124PubMed

133.

Inada M, Wang Y, Byrne MH et al (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 101:17192–17197PubMedCentralPubMed

134.

Stickens D, Behonick DJ, Ortega N et al (2004) Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883–5895PubMedCentralPubMed

135.

Neuhold LA, Killar L, Zhao W et al (2001) Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Investig 107:35–44PubMedCentralPubMed

136.

Little CB, Barai A, Burkhardt D et al (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60:3723–3733PubMedCentralPubMed

137.

Glasson SS, Askew R, Sheppard B et al (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644–648PubMed

138.

Majumdar MK, Askew R, Schelling S et al (2007) Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 56:3670–3674PubMed

139.

Stanton H, Rogerson FM, East CJ et al (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648–652PubMed

140.

Stetler Stevenson WG, Seo DW (2005) TIMP-2: an endogenous inhibitor of angiogenesis. Trends in molecular medicine 11:97–103PubMed

141.

Wang M, Sampson ER, Jin H et al (2013) MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther 15:R5PubMedCentralPubMed

142.

Enomoto H, Enomoto Iwamoto M, Iwamoto M et al (2000) Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275:8695–8702PubMed

143.

Inada M, Yasui T, Nomura S et al (1999) Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214:279–290PubMed

144.

Komori T, Yagi H, Nomura S et al (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764PubMed

145.

Kim HJ, Kim JH, Bae SC et al (2003) The protein kinase C pathway plays a central role in the fibroblast growth factorstimulated expression and transactivation activity of Runx2. J Biol Chem 278:319–326PubMed

146.

Takamoto M, Tsuji K, Yamashita T et al (2003) Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. J Endocrinol 177:413–421PubMed

147.

Tou L, Quibria N, Alexander JM (2001) Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs). Mol Cell Endocrinol 183:71–79PubMed

148.

Zhou YX, Xu X, Chen L et al (2000) A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9:2001–2008PubMed

149.

Zhao M, Qiao M, Harris SE et al (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha 1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278:27939–27944PubMed

150.

Zhao M, Qiao M, Harris SE et al (2004) Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 279:12854–12859PubMedCentralPubMed

151.

Shen R, Chen M, Wang YJ et al (2006) Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J Biol Chem 281:3569–3576PubMedCentralPubMed

152.

Shen R, Wang X, Drissi H et al (2006) Cyclin D1-cdk4 induce runx2 ubiquitination and degradation. J Biol Chem 281:16347–16353PubMedCentralPubMed

153.

Jeon EJ, Lee KY, Choi NS et al (2006) Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 281:16502–16511PubMed

154.

Jonason JH, Xiao G, Zhang M et al (2009) Post-transcriptional regulation of runx2 in bone and cartilage. J Dent Res 88:693–703PubMedCentralPubMed

155.

Akhtar N, Rasheed Z, Ramamurthy S et al (2010) MicroRNA-27b regulates the expression of MMP-13 in human osteoarthritis chondrocytes. Arthritis Rheum 62:1361–1371PubMedCentralPubMed

156.

Miyaki S, Nakasa T, Otsuki S et al (2009) MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 60:2723–2730PubMedCentralPubMed

157.

Yamasaki K, Nakasa T, Miyaki S et al (2009) Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 60:1035–1041PubMedCentralPubMed

Title: Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms
Authors: Bingjiang Xia
Di Chen
Jushi Zhang
Songfeng Hu
Hongting Jin
Peijian Tong
Publication date: 01-12-2014
Publisher: Springer US
Published in: Calcified Tissue International / Issue 6/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-014-9917-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2014

Preclinical Assessment of a New Magnetic Resonance-based Technique for Determining Bone Quality by Characterization of Trabecular Microarchitecture

Effect of Whole-Body Vibration on Calcaneal Quantitative Ultrasound Measurements in Postmenopausal Women: A Randomized Controlled Trial

Gaucher Disease and Bone Manifestations

Bone Geometry, Volumetric Bone Mineral Density, Microarchitecture and Estimated Bone Strength in Caucasian Females with Systemic Lupus Erythematosus. A Cross-Sectional Study Using HR-pQCT

Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major

Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page